摘要
慢性血栓栓塞性肺动脉高压(CTEPH)属于肺动脉高压的第四大类,以肺动脉血栓机化、肺血管重塑致血管狭窄或闭塞,肺动脉压力进行性升高,最终出现右心功能衰竭导致患者死亡。CTEPH发病机制有待进一步阐明。然而,对于CTEPH的诊断以及治疗方案尚需要探索,其预后及其机制尚未明确。本文对CTEPH病理机制及基础转化研究新进展进行梳理。
Chronic thromboembolic pulmonary hypertension(CTEPH),the fourth category of pulmonary hypertension,is characterized by pulmonary arterial thrombosis,pulmonary vascular remodeling which leads to vascular stenosis or occlusion,progressive increase in pulmonary arterial pressure,and eventually right heart failure.The pathogenesis of CTEPH remains to be further elucidated.The prognosis and mechanism of CTEPH are unclear.The diagnosis and treatment of CTEPH remains to be further explored.Here,the pathological mechanism and new progress in basic translational research of CTEPH are sorted out in the paper.
作者
郑浩
华晶
李强
季颖群
Zheng Hao;Hua Jing;Li Qiang;Ji Yingqun(Department of Pulmonary and Critical Care Medicine,Shanghai East Hospital,Tongji University,Shanghai 200120,China)
出处
《国际呼吸杂志》
2022年第21期1647-1652,共6页
International Journal of Respiration
基金
国家自然科学基金(82270116、8207011979)。
关键词
肺动脉高压
炎症
免疫疗法
抗原
表面
单细胞测序
非编码RNA
Pulmonary hypertension
Inflammation
Immunotherapy
Antigens,surface
Single-cell sequencing
Non-coding RNA